Company Overview
Snapshot
Founded in November 2019 by Yair Weinberger, Nicopharm operates with 1–10 employees. The company is currently in the R&D product stage.
Business overview
Nicopharm, a subsidiary of Omega Life Sciences, operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology. The company is engaged in pharmaceutical research and development.
Log in to access full profile ›Company Intelligence Q&A
- What is Nicopharm's current operational status?
- Nicopharm is currently non-active and ceased to operate in May 2022.
- When was Nicopharm founded?
- Nicopharm was founded in November 2019.
- Who is the founder of Nicopharm?
- Yair Weinberger is the founder of Nicopharm.
- What is Nicopharm's primary sector?
- Nicopharm's primary sector is Health Tech & Life Sciences, with a focus on Pharma & Medical Biotechnology.
- What is Nicopharm's current product stage?
- Nicopharm is currently in the R&D product stage, indicating it is focused on research and development activities for its pharmaceutical products.